PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver cirrhosis |
| Phenotype | C0022806|protein malnutrition |
| Sentences | 4 |
| PubMedID- 21518402 | Conclusion: les with bcaa-enriched nutrient therapy can improve protein malnutrition in patients with liver cirrhosis, and is more useful in the early stages of liver cirrhosis in improving hepatic parenchymal cell mass. |
| PubMedID- 23027617 | Branched-chain amino acids (bcaa), which improve protein malnutrition in patients with liver cirrhosis, reduce the risk of hepatocellular carcinoma in these patients with obesity. |
| PubMedID- 25789501 | We found that supplementation with branched-chain amino acids (bcaa), which improve protein malnutrition in patients with liver cirrhosis [38], significantly inhibited liver carcinogen diethylnitrosamine (den)-induced hepatocarcinogenesis as well as spontaneously occurring hepatic preneoplastic lesions in db/db obese and diabetic mice [34,39]. |
| PubMedID- 24273224 | Supplementation with branched-chain amino acids (bcaa), which are used to improve protein malnutrition in patients with liver cirrhosis, can also reduce the risk of hcc in obese cirrhotic patients. |
Page: 1